Literature DB >> 1442675

Yield of upper endoscopy in the evaluation of asymptomatic patients with Hemoccult-positive stool after a negative colonoscopy.

P C Hsia1, F H al-Kawas.   

Abstract

The yield of upper endoscopy in asymptomatic patients with positive fecal occult blood test (FOBT) and a negative colonoscopy was evaluated prospectively in 70 consecutive patients. Significant pathology was diagnosed in 19 patients (27%), eight patients with ulcers, five with arteriovenous malformations, three with esophageal or gastric varices, two with multiple erosions, and two with biopsy-proven Barrett's esophagus. Thirteen patients had iron deficiency anemia and demonstrated a 38% prevalence of significant pathology. Fifteen patients on nonsteroidal anti-inflammatory agents had a 30% prevalence of significant pathology. No statistically significant difference was noted between subgroups. In conclusion, asymptomatic patients without a colonic source to explain a positive FOBT often have significant lesions, on upper endoscopy. Iron deficiency anemia did not have an impact on pathology. Because treatment and follow-up plans were altered in many of the cases in which significant pathology was demonstrated, we conclude that upper endoscopy should be seriously considered for all asymptomatic patients with occult gastrointestinal bleeding and a negative colonoscopic examination.

Entities:  

Mesh:

Year:  1992        PMID: 1442675

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

Review 1.  Does this elderly patient have iron deficiency anaemia, and what is the underlying cause?

Authors:  O M Jolobe
Journal:  Postgrad Med J       Date:  2000-04       Impact factor: 2.401

2.  Positive occult blood and negative colonoscopy--should we perform gastroscopy?

Authors:  Mark T McLoughlin; Jennifer J Telford
Journal:  Can J Gastroenterol       Date:  2007-10       Impact factor: 3.522

3.  Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract.

Authors:  Tsung-Hsien Chiang; Yi-Chia Lee; Chia-Hung Tu; Han-Mo Chiu; Ming-Shiang Wu
Journal:  CMAJ       Date:  2011-08-02       Impact factor: 8.262

4.  Prevalence of gastric cancer versus colorectal cancer in Asians with a positive fecal occult blood test.

Authors:  Lukejohn W Day; John P Cello; Ma Somsouk; John M Inadomi
Journal:  Indian J Gastroenterol       Date:  2011-09-23

5.  Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer.

Authors:  H Nakama; B Zhang
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

Review 6.  Gastroscopy following a positive fecal occult blood test and negative colonoscopy: systematic review and guideline.

Authors:  Johane Allard; Roxanne Cosby; M Elisabeth Del Giudice; E Jan Irvine; David Morgan; Jill Tinmouth
Journal:  Can J Gastroenterol       Date:  2010-02       Impact factor: 3.522

7.  Is a fecal occult blood test a useful tool for judging whether to perform capsule endoscopy in low-dose aspirin users with negative colonoscopy and esophagogastroduodenoscopy?

Authors:  Hiroki Endo; Takayuki Kato; Eiji Sakai; Leo Taniguchi; Jun Arimoto; Harunobu Kawamura; Takuma Higurashi; Hidenori Ohkubo; Takashi Nonaka; Masataka Taguri; Masahiko Inamori; Takeharu Yamanaka; Takashi Sakaguchi; Yasuo Hata; Hajime Nagase; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2016-04-19       Impact factor: 7.527

8.  Bundling in medicare patients undergoing bidirectional endoscopy: how often does it happen?

Authors:  Hashem B El-Serag; Fang Xu; Prachi Biyani; Gregory S Cooper
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-01       Impact factor: 11.382

9.  A closer look at same-day bidirectional endoscopy.

Authors:  Jennifer Urquhart; Glenn Eisen; Douglas O Faigel; Nora Mattek; Jennifer Holub; David A Lieberman
Journal:  Gastrointest Endosc       Date:  2008-08-23       Impact factor: 9.427

10.  Prospective evaluation of gastrointestinal tract in patients with iron-deficiency anemia.

Authors:  T Kepczyk; S C Kadakia
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.